News

Model Marloes Horst named newest face of Maybelline New York

BY Antoinette Alexander

NEW YORK — Maybelline New York has tapped Dutch model Marloes Horst to be its newest face for the brand, joining a roster of prominent spokeswomen including Christy Turlington, Emily DiDonato and a host of others.

She will make her Maybelline New York debut in print and television advertising campaigns in April.

"Marloes embodies the Maybelline New York woman with her passion for makeup and her New York City energy and ambition," stated Jerome Bruhat, global brand president of Maybelline New York.

Horst has lit up the runway for Prada, posed for the Pirelli calendar and is a Victoria’s Secret regular. Currently, Marloes is the face for the DKNY “Be Delicious” fragrance and recently posed for the Sports Illustrated 50th Anniversary issue.

Horst has been featured on the covers of such magazines as Vogue, Harper’s Bazaar, Elle, L’Officiel and Jalouse and has been seen in advertising campaigns for Calvin Klein, Stella McCartney, Carolina Herrera, H&M, Valentino, Ralph Lauren, DKNY, Tommy Hilfiger Denim and Kenzo.
 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Sunovion Pharmaceuticals announces availability of Aptiom

BY Ryan Chavis

MARLBOROUGH, Mass. — Sunovion Pharmaceuticals on Monday announced that Aptiom (eslicarbazepine acetate), a once-daily antiepileptic drug, is now available across the United States.

The drug, which received approval from the Food and Drug Administration on Nov. 8, 2013, is a prescription medicine used with other medicines to treat partial-onset seizures. The drug is available in four table strengths: 200 mg, 400 mg, 600 mg and 800 mg; it can be taken whole or crushed, with food or without.

“Epilepsy is a serious condition that not only affects the people who suffer from seizures, but also their family, caregivers and friends,” said Michael R. Sperling, M.D., professor of neurology at Thomas Jefferson University and director of the Jefferson Comprehensive Epilepsy Center in Philadelphia. “Approximately one-third of those with epilepsy still have inadequate seizure control despite treatment, so we need new therapies. Aptiom is a welcome addition to our therapeutic toolkit that may help some patients.”

Epilepsy is one of the most common neurological disorders and affects nearly 2.2 million people in the United States, the company said. Partial-onset seizures are the most prevalent type of seizure and are connected with 60% of new epilepsy diagnoses.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Upsher-Smith, Hamacher Resource Group launch first in e-book series for independent pharmacists

BY Antoinette Alexander

WAUKESHA, Wis. — Upsher-Smith has announced the release of the first in a series of educational e-books authored by Hamacher Resource Group and created for independent community pharmacists.

The first e-book in the series is “Community Pharmacy: Foundation for the Future,” and was developed to assist independent pharmacists/owners with assessing the state of their business and preparing strategies for continued growth.

Upsher-Smith collaborated with HRG to develop the series because of its 30-plus years serving independent pharmacy and objective position in the industry.

“We have worked with HRG for a number of years and were confident that their expertise in independent pharmacy would lead to insightful content and practical exercises that pharmacists could use to enhance their plans for the future of their pharmacy,” stated Scott Hussey, SVP, commercial operations at Upsher-Smith.

Independent pharmacists/owners interested in downloading a copy of “Community Pharmacy: Foundation for the Future,” can visit Hamacher.com/FoundationForTheFuture. There is also an email link to Upsher-Smith on the page that pharmacists can use to provide feedback about the book, as well as suggest topics for future e-books.

“This was a very enjoyable project for us and we were thrilled to put some of our acquired knowledge into a concise, digestible format to help independent pharmacists prepare for future success,” stated Dave Wendland, HRG VP and member of the owners group. ”We’re looking forward to collaborating with Upsher-Smith on the remaining e-books in the series and hope to release the second and third books before the end of the year.”

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?